(Press-News.org) Ljubljana, Slovenia – May 2, 2013 – A study published today in PLOS ONE finds that Droplet Digital PCR (ddPCR™) technology is suitable for routine analysis of genetically modified organisms (GMOs) in food, feed, and seeds.
More than 60 countries representing 40 percent of the world's population require labeling of food and feed when GMOs reach certain thresholds. Screening for and quantifying GMOs is essential to the integrity of this labeling policy.
"Droplet Digital PCR could replace or be a good alternative to qPCR, the current benchmark in GMO quantification," said Dr. Dany Morisset, the paper's lead author and a researcher at Slovenia's National Institute of Biology. Dr. Morisset, in collaboration with the EU Reference Laboratory for GM Food and Feed (EU-RL GMFF), also coordinates an international R&D project to standardize screening methods for detecting GMOs in food and feed.
The paper showed that Droplet Digital PCR (ddPCR™) technology is more accurate and reliable than real-time quantitative PCR (qPCR) for quantifying GMOs, especially at low levels. Study authors also found that the ddPCR method meets international food standards of applicability and practicality.
qPCR has Drawbacks for Detecting GMOs
The most common technique for quantifying the presence of GMOs is qPCR, thanks to its accuracy and precision. However, according to Dr. Morisset, qPCR has several drawbacks. It is often unreliable and inaccurate when quantifying very small numbers of DNA targets or when those targets are part of complex matrices such as foods or feed that contain inhibitory substances.
A 2010 research study found that chamber digital PCR (cdPCR) delivered accurate quantification at low target copy number without the need for a standard curve. The matrix also did not inhibit cdPCR because as an end-point assay the data are less affected by amplification efficiency. However, Dr. Morisset says its high costs make cdPCR impractical for real-world use.
The ddPCR System Meets or Exceeds International Recommendations for Performance Parameters
Dr. Morisset learned about Droplet Digital PCR technology, which was developed as an alternative to cdPCR due to its easy workflow, low cost and high throughput. Commercialized as the QX100™ Droplet Digital PCR system, the ddPCR system provides thousands more partitions than in cdPCR, resulting in greater precision and per-sample costs that are up to 150 times less.
The Slovenian researchers analyzed food and feed matrices containing different percentages of a well-characterized GMO transgene. They found the ddPCR system's performance parameters (precision, accuracy, sensitivity, and dynamic range) complied with the guidelines of the EU-RL GMFF and were comparable or superior to those for qPCR. Compared with the conventional qPCR assay, the ddPCR assay offered better accuracy at low target concentrations and greater tolerance to inhibitors found in matrices such as wheat flour and feed.
ddPCR Technology is Practical for Everyday Lab Use
International food safety standards specify that new methodologies should be easy for labs to implement in terms of cost, time, and workflow.
In the authors' hands, a ddPCR assay requires 190 minutes and a qPCR assay takes 160 minutes for the typical number of samples run in parallel in mid-size GMO laboratories. However, due to the greater number of PCR reactions required per sample in the qPCR assay, the time and expense of the qPCR assay grows rapidly with increasing sample throughput. Droplet Digital PCR is also simpler to set up and involves less hands-on labor than qPCR.
Dr. Morisset's findings reveal that ddPCR is a less expensive alternative to qPCR due to the lower number of reactions. Droplet Digital PCR capitalizes on its ability to "duplex" as opposed to qPCR's traditional approach of performing separate assays for both control and transgene targets. The ddPCR assay also doesn't require reactions for a standard curve or dilutions due to lower anticipated inhibition.
###
Research Funding Sources
This work was cofinanced by the Slovenian Ministry of Economic Development and Technology, Metrology Institute (MIRS) in the frame of contract 640118/2008/67 on performing activities as a holder of the national standard MIRS/NIB/FITO for the amount of substances in foods of plant origin.
About the National Institute of Biology
The National Institute of Biology is a public nonprofit organization performing basic and applied research in the fields of biology, biotechnology, medicine, and ecology as well as interdisciplinary fields, joining biosciences with statistics and bioinformatics. It employs approximately 130 people and was awarded the ISO 9001 quality certificate for all its activities. The Department of Biotechnology and Systems Biology focuses its research and development activities on three topics: omics, microorganisms, and genetically modified organisms (GMOs). As a national reference laboratory, the department is a member of the European network of GMO laboratories (ENGL) and performs official GMO testing in seed, food, and feed samples under the ISO17025 accreditation.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned
worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs approximately 7,300 people globally and had revenues exceeding $2 billion in 2012. For more information, please visit http://www.biorad.com.
PLOS ONE study: Droplet Digital™ PCR works for GMO quantification
2013-05-03
ELSE PRESS RELEASES FROM THIS DATE:
Making cancer less cancerous
2013-05-03
Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs.
"This master regulator is normally turned off in adult cells, but it is very active during embryonic development and in all highly aggressive tumors studied to date," says Linda Resar, M.D., an associate professor of medicine, ...
Increases in heart disease risk factors may decrease brain function
2013-05-03
Brain function in adults as young as 35 may decline as their heart disease risk factors increase, according to new research in the American Heart Association journal Stroke.
"Young adults may think the consequences of smoking or being overweight are years down the road, but they aren't," said Hanneke Joosten, M.D., lead author and nephrology fellow at the University Medical Center in Groningen, The Netherlands.
"Most people know the negative effects of heart risk factors such as heart attack, stroke and renal impairment, but they do not realize it affects cognitive ...
Researchers estimate a cost for universal access to energy
2013-05-03
Universal access to modern energy could be achieved with an investment of between 65 and 86 billion US dollars a year up until 2030, new research has shown.
The proposed investments are higher than previous estimates but equate to just 3-4 per cent of current investments in the global energy system.
The findings, which have been presented today, 3 May, in IOP Publishing's Environmental Research Letters, also include, for the first time, the policy costs for worldwide access to clean-combusting cooking fuels and stoves by 2030.
Access to electricity and clean-combusting ...
Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
2013-05-03
Lugano-CH, Brussels-BE, 2 May 2013 -- A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.
The new findings show that better individual risk prediction for women with these cancers is getting nearer, says study author Prof Michael Gnant from the Medical University of Vienna, Austria.
Prof Gnant reported the findings at the 5th IMPAKT ...
How graphene and friends could harness the Sun's energy
2013-05-03
University of Manchester and National University of Singapore researchers have shown how building multi-layered heterostructures in a three-dimensional stack can produce an exciting physical phenomenon exploring new electronic devices.
The breakthrough, published in Science, could lead to electric energy that runs entire buildings generated by sunlight absorbed by its exposed walls; the energy can be used at will to change the transparency and reflectivity of fixtures and windows depending on environmental conditions, such as temperature and brightness.
The isolation ...
Robotic insects make first controlled flight
2013-05-03
VIDEO:
The tiny robot flaps its wings 120 times per second using piezoelectric actuators -- strips of ceramic that expand and contract when an electric field is applied. Thin hinges of...
Click here for more information.
Cambridge, Mass. - May 2, 2013 - In the very early hours of the morning, in a Harvard robotics laboratory last summer, an insect took flight. Half the size of a paperclip, weighing less than a tenth of a gram, it leapt a few inches, hovered for a moment ...
Dual-color lasers could lead to cheap and efficient LED lighting
2013-05-03
A new semiconductor device capable of emitting two distinct colours has been created by a group of researchers in the US, potentially opening up the possibility of using light emitting diodes (LEDs) universally for cheap and efficient lighting.
The proof-of-concept device, which has been presented today, 3 May, in IOP Publishing's journal Semiconductor Science and Technology, takes advantage of the latest nano-scale materials and processes to emit green and red light separated by a wavelength of 97 nanometres—a significantly larger bandwidth than a traditional semiconductor.
Furthermore, ...
Cyberthreats must require governments and businesses to be 'cyberrisk intelligent'
2013-05-03
HOUSTON – (May 2, 2013) – In an age where cybersecurity is of foremost interest for governments and businesses, public and private organizations must deploy risk-intelligence governance to secure their digital communications and resources from eavesdropping, theft or attack, according to a new paper from Rice University's Baker Institute for Public Policy.
The paper, "Risk-Intelligent Governance in the Age of Cyberthreats," was authored by Christopher Bronk, a fellow in information technology policy at the Baker Institute. Against the backdrop of technology experts and ...
'Dark genome' is involved in Rett Syndrome
2013-05-03
Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding long chain RNA sequences (lncRNA) in Rett syndrome.
These molecules act as supervisor agents responsible of 'switch on' or 'switch off' other genes in our genome that regulate the activity of neurons. The work has been published in the last issue of the journal RNA Biology.
Dark genome
Only 5% of our genetic material are genes that encode proteins. The remaining ...
Increased risk of heart attack and death with progressive coronary artery calcium buildup
2013-05-03
LOS ANGELES (May 2, 2013) – Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn't have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.
The study, conducted at Los Angeles Biomedical Research Institute (LA BioMed) and five other sites, suggests more frequent monitoring of patients with coronary artery calcium accumulations could help determine the risk of heart attacks and ...